Clinical Trial Update: A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effect of inhaling a single dose of GW642444M in patients with chronic obstructive pulmonary disease; results were posted after com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GW642444M (GW642444M)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2013-12-30